{
    "clinical_study": {
        "@rank": "110768", 
        "acronym": "SOLO-1", 
        "arm_group": {
            "arm_group_label": "OSNA", 
            "description": "Patient cases with cT1-3, N0 early breast cancer, who previously had intraoperative sentinel lymph node (SLN) evaluation by one-step nucleic acid amplification (OSNA) assay with a complete axillary dissection."
        }, 
        "brief_summary": {
            "textblock": "This is a retrospective, multicentric cohort study of patient cases with cT1-3, N0 early\n      breast cancer, who previously had intraoperative sentinel lymph node (SLN) evaluation by\n      one-step nucleic acid amplification (OSNA) assay with a complete axillary dissection.\n\n      The aim of the present study is to assess the intraoperative positive SLN total tumor load\n      (TTL) obtained from the OSNA assay and to determine whether this TTL predicts non-SLN\n      metastasis in patients with clinically node-negative early-stage breast cancer."
        }, 
        "brief_title": "Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pathologically confirmed invasive breast carcinoma\n\n          -  Stage T1-3,N0 evaluated by physical exam or imaging according to AJCC v.7 and best\n             clinical local practices\n\n          -  Intraoperative evaluation of sentinel lymph node (SLN) by OSNA\n\n          -  Complete dissection of axillary lymph nodes after the evaluation of the SLNs by OSNA\n\n          -  Pathology report of the tumor and dissected lymph nodes that includes the following\n             information:\n\n               -  primary tumor size (mm), tumor grade (Scarff-Bloom Richardson), estrogen\n                  receptor status\n\n               -  progesterone receptor status\n\n               -  HER2 status (ASCO/CAP guidelines)\n\n               -  Ki67 index\n\n               -  presence/absence of lymphovascular invasion\n\n               -  total number of sentinel and non-sentinel lymph nodes dissected during surgery\n\n               -  total number of positive and negative sentinel and non-sentinel lymph nodes,\n                  *size of the metastasis in both sentinel and non-sentinel lymph nodes\n\n               -  total tumoral load in each sentinel lymph node, expressed as number of CK19 mRNA\n                  copies per microliter.\n\n        Exclusion Criteria:\n\n          -  Patients who underwent neoadjuvant chemotherapy\n\n          -  CK19-negative breast tumor\n\n          -  ALND with <10 lymph nodes\n\n          -  In situ carcinoma only\n\n          -  Metastatic breast cancer at time of diagnosis"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with cT1-3, N0 breast cancer, who had intraoperative SLN evaluation by OSNA assay\n        with a complete axillary lymph node dissection."
            }
        }, 
        "enrollment": {
            "#text": "701", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669265", 
            "org_study_id": "SOLTI-1113"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast cancer", 
            "OSNA", 
            "sentinel lymph node"
        ], 
        "lastchanged_date": "December 10, 2012", 
        "link": {
            "description": "SOLTI Breast Cancer Research Group", 
            "url": "http://www.gruposolti.org"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Vall d\u00b4Hebron University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario de Bellvitge"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Coru\u00f1a", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Cl\u00ednico Universitario de Santiago de Compostela"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Palmas", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario de Gran Canaria Doctor Negrin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lleida", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Arnau de Vilanova"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario 12 de Octubre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salamanca", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario de Salamanca"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seville", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Virgen Del Rocio"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }, 
                    "name": "Instituto Valenciano de Oncolog\u00eda"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer", 
        "overall_official": [
            {
                "affiliation": "Vall d\u00b4Hebron University Hospital", 
                "last_name": "Vicente Peg, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Vall d\u00b4Hebron University Hospital", 
                "last_name": "Isabel Rubio, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Vall d\u00b4Hebron University Hospital", 
                "last_name": "Martin Espinosa, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Estimate the negative predictive value of the technique OSNA for the cutoff point that maximizes (tentatively, 10,000 to 15,000 copies / uL) of axillary lymph node involvement in breast cancer early N0.", 
            "measure": "Estimate the negative predictive value of the technique OSNA.", 
            "safety_issue": "No", 
            "time_frame": "At time of surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669265"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "citation": "Peg V, Espinosa-Bravo M, Vieites B, Vilardell F, Ant\u00fanez JJ, Salas MS, Sansano I, Delgado S\u00e1nchez JJ, Pinto W, Gozalbo F, Petit A, Rubio I. Intraoperative molecular analysis of sentinel lymph node as a new predictor of axillary status in early breast cancer. Poster session presented at: 35th Annual San Antonio Breast Cancer Symposium (SABCS); 2012 December 4th-8th; San Antonio, Texas, United States."
        }, 
        "secondary_outcome": [
            {
                "description": "ROC curve (Receiver Operating Characteristic) from the true and false positives and negatives of OSNA test for different cutoffs", 
                "measure": "ROC curve that describes the assay", 
                "safety_issue": "No", 
                "time_frame": "At time of surgery"
            }, 
            {
                "description": "Probability that OSNA in sentinel lymph nodes (SLN) is positive given that there is involvement of non-sentinel lymph nodes (NSLN)", 
                "measure": "Sensitivity of the assay", 
                "safety_issue": "No", 
                "time_frame": "At time of surgery"
            }, 
            {
                "description": "Probability that OSNA in SLN is negative because there is no involvement of NSLN", 
                "measure": "Specificity of the assay", 
                "safety_issue": "No", 
                "time_frame": "At time of surgery"
            }, 
            {
                "description": "Likelihood ratio of positive and negative results", 
                "measure": "Likelihood ratio for the cutoff of 10,000-15,000 copies/uL", 
                "safety_issue": "No", 
                "time_frame": "At time of surgery"
            }, 
            {
                "measure": "Positive predictive value at the cutoff of 10.000-15.000 copies/\u03bcL.", 
                "safety_issue": "No", 
                "time_frame": "At time of surgery"
            }
        ], 
        "source": "SOLTI Breast Cancer Research Group", 
        "sponsors": {
            "collaborator": {
                "agency": "Sysmex America, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "SOLTI Breast Cancer Research Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}